Suscribirse

Umbelliferone (7-hydroxycoumarin): A non-toxic antidiarrheal and antiulcerogenic coumarin - 28/08/20

Doi : 10.1016/j.biopha.2020.110432 
Luisa Ferreira Cruz a, , Geisa Fantini de Figueiredo a, Lidiane Paula Pedro a, Yuri Martins Amorin a, Jessica Tauany Andrade b, Tiago Faustino Passos a, Felipe Fernandes Rodrigues a, Israel Lucas Antunes Souza a, Thaís Paula Rodrigues Gonçalves c, Luciana Alves Rodrigues dos Santos Lima c, Jaqueline Maria Siqueira Ferreira b, Marcelo Gonzaga de Freitas Araújo a
a Laboratory of Pharmacology, Federal University of São João Del-Rei, Sebastião Gonçalves Coelho, 400, Chanadour, 35501-296, Divinópolis, MG, Brazil 
b Laboratory of Medical Microbiology, Federal University of São João Del-Rei, Sebastião Gonçalves Coelho, 400, Chanadour, 35501-296, Divinópolis, MG, Brazil 
c Laboratory of Phytochemistry, Federal University of São João Del-Rei, Campus Centro Oeste Dona Lindu, Divinópolis, MG, Brazil 

Corresponding author at: Laboratory of Pharmacology, Federal University of São João Del-Rei, Campus Centro Oeste Dona Lindu, 400 Sebastião Gonçalves Coelho St., Chanadour, ZIP Code 35501-296, Divinópolis, MG, Brazil.Laboratory of PharmacologyFederal University of São João Del-ReiCampus Centro Oeste Dona Lindu, 400 Sebastião Gonçalves Coelho St., ChanadourDivinópolisMGZIP Code 35501-296Brazil

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

páginas 8
Iconografías 3
Vídeos 0
Otros 0

Graphical abstract




El texto completo de este artículo está disponible en PDF.

Highlights

Umbelliferone has no mutagenic and toxic potential in vivo at the doses tested.
Umbelliferone has gastric protective activity in vivo.
Umbelliferone has antidiarrheal activity in vivo.

El texto completo de este artículo está disponible en PDF.

Abstract

Gastrointestinal diseases are very common problems; available treatments are very limited and come with a range of side effects. Coumarins are an extensive class of phenolic compounds that can be found in plants, fungi and bacteria. The 7-hydroxycoumarin, also known as umbelliferone (UMB), is a compound that comes from coumarin and has been showing biological activities in other studies. As of this scenario, the present study was designed to evaluate the acute oral toxicity, mutagenic, antidiarrheal, anti-bacterial, and antiulcerogenic effects, and antioxidant capacity of UMB. An investigation was conducted through the hippocratic screening method and through histopathological analysis in animals to evaluate the effects of acute oral administration of a dose of 50, 100 and 200 mg/kg of UMB. A micronucleus test on peripheral blood of Swiss mice, which were orally treated with three doses (50, 100 and 200 mg/kg), was conducted to evaluate mutagenic activities. The antiulcerogenic activity was accomplished through the ethanol-induced damage method. Antidiarrheal activities were tested for inducing diarrhea with castor oil and evaluating intestinal transit duration; additionally, the antimicrobial effect against some enteropathogenic bacteria was analyzed. Finally, the antioxidant capability was determined by the capacity of the UMB sample to kidnap the stable radical 2,2-diphenyl-1-picrylhydrazyl. Of the evaluated doses, signs of toxicity after acute administration of the compound were not observed. UMB presented antiulcerogenic activity (100 and 200 mg/kg), which was explained because of its antioxidant capacity. A gastro protective effect was similar to the positive control, and the UMB was able to significantly reduce intestinal transit, and also diarrheal symptoms. Furthermore, UMB had an anti-bacterial effect with minimum inhibitory concentration fluctuating between 62.5 and 1000 μg/mL. Based on these findings, we can suggest that UMB has important biological activities in vivo and in vitro and is not toxic under the evaluated circumstances, which demonstrates its large potential for pharmacological use.

El texto completo de este artículo está disponible en PDF.

Abbreviations : UMB, DPPH, DMSO, CP, b.w., IP, PCEMNs, NCEs, PI, MIC, MBC, BHT

Keywords : Coumarin, Umbelliferone, Diarrhea, Mutagenicity, Antiulcerogenic


Esquema


© 2020  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 129

Artículo 110432- septembre 2020 Regresar al número
Artículo precedente Artículo precedente
  • Low dose HSP90 inhibition with AUY922 blunts rapid evolution of metastatic and drug resistant phenotypes induced by TGF-? and paclitaxel in A549 cells
  • Nickolas A. Bacon, Isabel Larre, Abdalla A. Lawag, Carlen Merritt, Mackinzie Smith, Matthew Rosolen, Vincent E. Sollars
| Artículo siguiente Artículo siguiente
  • Huoxuezhitong capsule ameliorates MIA-induced osteoarthritis of rats through suppressing PI3K/ Akt/ NF-?B pathway
  • Linjie Ju, Peipei Hu, Ping Chen, Xue Xue, Zhuoqun Li, Feiyan He, Zhixia Qiu, Jun Cheng, Fang Huang

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.